A Comprehensive Reference for BRCA1/2 Genes Pathogenic Variants in Iran: Published, Unpublished and Novel

Overview

Journal Fam Cancer

Publisher Springer

Specialty Oncology

Date 2021 Mar 23

PMID 33754277

Authors

Keivan Majidzadeh-A

Shiva Zarinfam

Nasrin Abdoli

Fatemeh Yadegari

Rezvan Esmaeili

Leila Farahmand

Azin Teimourzadeh

Mahdieh Taghizadeh

Mansoor Salehi

Mohamad Zamani

Affiliations

Soon will be listed here.

Abstract

BRCA1 and BRCA2 are two prominent genes that account for about 20-40% of inherited breast cancer. Mutations in these genes are often associated with clustering of especially early-onset cancers in the family. The spectrum of BRCA variants showed a significant difference between geographic regions and ethnicities. The frequency and spectrum of BRCA mutations in Iran, a country in southwest Asia, have not yet been thoroughly studied. Here, for the first time, all published and not published BRCA pathogenic variants are presented. Among 1040 high risk families (1258 cases) which were detected, 116 families were found to carry pathogenic variants in either BRCA1 or BRCA2. Altogether 89 distinct types of pathogenic variants have been detected in Iran, including 41 in BRCA1 and 48 in BRCA2. 16 out of 89 mutations had not been previously reported in Iran and are presented for the first time in this article, among which 4 mutations are novel worldwide. 20% of families had one of the seven most commonly observed mutations, including c.81-1G > C, c.66_67delAG, c.4609C>T, c.1568delT, c.1961delA, in BRCA1 and: c.3751_3752insA, c.8585dupT in BRCA2. Combining the data from published articles and our study which has not been published before, a comprehensive table is created as a reference for entire BRCA pathogenic variants and their frequencies in Iran.

References

Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A . Breast cancer in Iran: a review of 903 case records. Public Health. 2000; 114(2):143-5. DOI: 10.1038/sj.ph.1900623. View

Ford D, Easton D, Stratton M, Narod S, Goldgar D, Devilee P . Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998; 62(3):676-89. PMC: 1376944. DOI: 10.1086/301749. View

Janavicius R . Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J. 2012; 1(3):397-412. PMC: 3405339. DOI: 10.1007/s13167-010-0037-y. View

Zhang J, Fackenthal J, Zheng Y, Huo D, Hou N, Niu Q . Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. Breast Cancer Res Treat. 2012; 134(2):889-94. DOI: 10.1007/s10549-012-2136-z. View

Villarreal-Garza C, Alvarez-Gomez R, Perez-Plasencia C, Herrera L, Herzog J, Castillo D . Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer. 2014; 121(3):372-8. PMC: 4304938. DOI: 10.1002/cncr.29058. View

Kang E, Seong M, Park S, Lee J, Lee J, Kim L . The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat. 2015; 151(1):157-68. DOI: 10.1007/s10549-015-3377-4. View

Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M . The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997; 336(20):1401-8. DOI: 10.1056/NEJM199705153362001. View

Hartge P, Struewing J, Wacholder S, Brody L, Tucker M . The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet. 1999; 64(4):963-70. PMC: 1377820. DOI: 10.1086/302320. View

Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C . Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst. 1999; 91(14):1241-7. DOI: 10.1093/jnci/91.14.1241. View

10.

Yassaee V, Zeinali S, Harirchi I, Jarvandi S, Mohagheghi M, Hornby D . Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res. 2002; 4(4):R6. PMC: 116720. DOI: 10.1186/bcr443. View

11.

Yassaee V, Ravesh Z, Soltani Z, Hashemi-Gorji F, Poorhosseini S, Anbiaee R . Mutation Spectra of BRCA Genes in Iranian Women with Early Onset Breast Cancer - 15 Years Experience. Asian Pac J Cancer Prev. 2016; 17(S3):149-53. DOI: 10.7314/apjcp.2016.17.s3.149. View

12.

Pietschmann A, Mehdipour P, Atri M, Hofmann W, Hosseini-Asl S, Scherneck S . Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families. J Cancer Res Clin Oncol. 2005; 131(8):552-8. DOI: 10.1007/s00432-005-0678-8. View

13.

Keshavarzi F, Noughani A, Ayoubian M, Zeinali S . Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer. Iran J Public Health. 2012; 40(2):57-66. PMC: 3481774. View

14.

Keshavarzi F, Javadi G, Zeinali S . BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients. Fam Cancer. 2011; 11(1):57-67. DOI: 10.1007/s10689-011-9477-3. View

15.

Saleh-Gohari N, Mohammadi-Anaie M, Kalantari-Khandani B . BRCA1 Gene Mutations in Breast Cancer Patients from Kerman Province, Iran. Iran J Cancer Prev. 2014; 5(4):210-5. PMC: 4209574. View

16.

Zorrieh Zahra A, Kadkhoda S, Behjati F, Aghakhani Moghaddam F, Badiei A, SiratI F . Mutation Screening of BRCA Genes in 10 Iranian Males with Breast Cancer. Int J Mol Cell Med. 2016; 5(2):114-22. PMC: 4947216. View

17.

Mehrgou A, Akouchekian M, Hemati S . Investigating of variations in BRCA1 gene in Iranian families with breast cancer. Med J Islam Repub Iran. 2019; 32:87. PMC: 6376998. DOI: 10.14196/mjiri.32.87. View

18.

Laitman Y, Friebel T, Yannoukakos D, Fostira F, Konstantopoulou I, Figlioli G . The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries. Hum Mutat. 2019; 40(11):e1-e23. DOI: 10.1002/humu.23842. View

19.

Ataei-Kachouei M, Nadaf J, Akbari M, Atri M, Majewski J, Riazalhosseini Y . Double Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome Sequencing. Iran J Public Health. 2015; 44(10):1348-52. PMC: 4644579. View

20.

Ghaderi A, Talei A, Farjadian S, Mosalaei A, Doroudchi M, Kimura H . Germline BRCA1 mutations in Iranian women with breast cancer. Cancer Lett. 2001; 165(1):87-94. DOI: 10.1016/s0304-3835(01)00394-9. View